A clinical-stage biotechnology company focused on developing immunotherapies that stimulate the immune system to treat cancer and other diseases. Its research has centered on the STING pathway and other immune-modulating platforms, with programs evaluated through early- and mid-stage clinical trials...
No congressional trades have been disclosed for Aduro Biotech Inc (ADRO) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.